1. VEGFR-3 and CXCR4 as predictive markers for treatment with fluorouracil, leucovorin plus either oxaliplatin or cisplatin in patients with advanced esophagogastric cancer: a comparative study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)
   Thomas Thomaidis et al, 2014, BMC Cancer CrossRef
2. Antitumorigenic potential of STAT3 alternative splicing modulation
   F. Zammarchi et al, 2011, Proceedings of the National Academy of Sciences CrossRef
3. Strategy of STAT3β cell-specific expression in macrophages exhibits antitumor effects on mouse breast cancer
   W Dang et al, 2015, Gene Ther CrossRef
4. Inhibition of cathepsin S confers sensitivity to methyl protodioscin in oral cancer cells via activation of p38 MAPK/JNK signaling pathways
   Ming-Ju Hsieh et al, 2017, Sci. Rep. CrossRef
5. STAT Activation in Malignancies: Roles in Tumor Progression and in the Generation of Antineoplastic Effects of IFNs
   Ben X. Wang et al, 2013, Journal of Interferon & Cytokine Research CrossRef
6. Cathepsin S attenuates endosomal EGFR signalling: A mechanical rationale for the combination of cathepsin S and EGFR tyrosine kinase inhibitors
   Chien-Chang Huang et al, 2016, Sci Rep CrossRef
7. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
   Takahiro Kishikawa et al, 2015, World J. Gastroenterol. CrossRef
8. CXCR4 overexpression is correlated with poor prognosis in colorectal cancer
   Chao Xu et al, 2018, Life Sciences CrossRef
9. Systemic Administration of a Cyclic Signal Transducer and Activator of Transcription 3 (STAT3) Decoy Oligonucleotide Inhibits Tumor Growth without Inducing Toxicological Effects
   Malabika Sen et al, 2014, Mol Med CrossRef
10. Monitoring tumour burden and therapeutic response through analysis of circulating tumour DNA and extracellular RNA in multiple myeloma patients
    Sridurga Mithraprabhu et al, 2019, Leukemia CrossRef
11. Z-FL-COCHO, a cathepsin S inhibitor, enhances oxaliplatin-mediated apoptosis through the induction of endoplasmic reticulum stress
    Seung Un Seo et al, 2018, Exp Mol Med CrossRef
12. Gastric Cancer with Radiographically Occult Metastatic Disease: Biology, Challenges, and Diagnostic Approaches
    Aravind Sanjeevaiah et al, 2020, Cancers CrossRef
13. Direct Serum Assay for Cell-Free Bmi-1 mRNA and Its Potential Diagnostic and Prognostic Value for Colorectal Cancer
    Xin Zhang et al, 2015, Clin Cancer Res CrossRef
14. Alterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis
    Gauri Shishodia et al, 2015, Mol Cancer CrossRef
15. Plasma mRNA expression levels of BRCA1 and TS as potential predictive biomarkers for chemotherapy in gastric cancer
    Jie Shen et al, 2014, J Transl Med CrossRef
16. Modulation of RNA Splicing by Oligonucleotides: Mechanisms of Action and Therapeutic Implications
    Olga V. Sergeeva et al, 2022, Nucleic Acid Therapeutics CrossRef
17. Bmi-1 directly upregulates glucose transporter 1 in human gastric adenocarcinoma
    Ying Guo et al, 2022 CrossRef
18. lncRNA HOTAIR promotes gastric cancer proliferation and metastasis via targeting miR-126 to active CXCR4 and RhoA signaling pathway.
    Jun Xiao et al, 2019, Cancer Med CrossRef